Rinucumab, CAS 1569263-06-4

Product Description: Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487.

CAS Number: 1569263-06-4

Molecular Weight: N/A

Research Area: Metabolic Disease

Solubility: 10 mM in DMSO

Target: PDGFR

• SKU: MEXHY-P99402-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99402-5
• Green Labware: No
• Package Unit: 5mg
• Quantity Unit: STK